COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,970 Articles (22,604 medRxiv, 8,366 bioRxiv)

Most recent first Previous |  Page 492: Articles 4911-4920  | Next

The effect of previous SARS-CoV-2 infection and COVID-19 vaccination on SARS-CoV-2 Omicron infection and relation with serological response - a prospective cohort study
de Gier, B., Huiberts, A. J., Hoeve, C. E., den Hartog, G., van Werkhoven, H. C. H., van Binnendijk, R., Hahne, S. J. M., de Melker, H. E., van den Hof, S., Knol, M. J.
10.1101/2023.01.09.23284334 — Posted: 2023-01-09
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from 12 July 2021 to 6 June 2022: a prospective cohort study
Huiberts, A. J., de Gier, B., Hoeve, C. E., de Melker, H. E., Hahne, S. J. M., den Hartog, G., Grobbee, D. E., van de Wijgert, J. H. H. M., van den Hof, S., Knol, M. J.
10.1101/2023.01.09.23284335 — Posted: 2023-01-09
SARS-CoV-2 molecular testing and whole genome sequencing following RNA recovery from used BinaxNOW COVID-19 Antigen Self Tests
Nguyen, P.-V., Carmola, L. R., Wang, E., Bassit, L., Rao, A., Greenleaf, M., Sullivan, J. A., Martin, G., Lam, W., Waggoner, J., Piantadosi, A.
10.1101/2023.01.09.23284337 — Posted: 2023-01-09
Research on the mental health status of frontline medical staff during the normalization of the COVID-19 pandemic
sun, n., Li, L., Xu, J., Zhou, s., Li, H., Yang, s., Fan, C.
10.1101/2023.01.09.23284361 — Posted: 2023-01-09
The importance of increasing primary vaccinationsagainst COVID-19 in Europe
Boëlle, P.-Y., Valdano, E.
10.1101/2023.01.09.23284297 — Posted: 2023-01-09
Long Covid symptoms and diagnosis in primary care: a cohort study using structured and unstructured data in The Health Improvement Network primary care database
Shah, A. D., Subramanian, A. D., Lewis, J., Dhalla, S., Ford, E., Haroon, S., Kuan, V., Nirantharakumar, K.
10.1101/2023.01.06.23284202 — Posted: 2023-01-09
Degree of immunoglobulin kappa light chain glycosylation of anti-spike SARS CoV-2 antibodies correlates with COVID-19 severity.
Grigaite, R., Iles, J. K., Harding, S., Patel, R., Wallis, G., Iles, R. K.
10.1101/2023.01.06.23284259 — Posted: 2023-01-09
Content Analysis of YouTube Videos Related to E-cigarettes and COVID-19
Lee, J., Murthy, D., Kong, G.
10.1101/2023.01.06.23284266 — Posted: 2023-01-09
The incidence of COVID-19-related hospitalisation in migrants in the UK: Findings from the Virus Watch prospective community cohort study
Fong, W. L. E., Nguyen, V. G., Burns, R., Boukari, Y., Beale, S., Braithwaite, I., Byrne, T. E., Geismar, C., Fragaszy, E., Hoskins, S., Kovar, J., Navaratnam, A. M., Oskrochi, Y., Patel, P., Tweed, S., Yavlinsky, A., Hayward, A. C., Aldridge, R. W.
10.1101/2023.01.06.22283653 — Posted: 2023-01-07
Down-regulation of MALAT1 is a hallmark of tissue and peripheral proliferative T cells in COVID-19
Dey, S., Ashwin, H., Milross, L., Hunter, B., Maho, J., Filby, A. J., Fisher, A. J., Kaye, P. M., Lagos, D.
10.1101/2023.01.06.23284229 — Posted: 2023-01-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).